Allez à nos transactions
Placements Privés | Soins de la Santé

Monument MicroCap Partners has sold Montgomery DME to Incline Equity Partners

Monument MicroCap Partners, LLC (MMP) has sold Montgomery DME (MDME) to Incline Equity Partners.

MDME is a leading provider of durable medical equipment rentals to the hospice market, including beds, oxygen systems, wheelchairs and bath safety products. The company acts as a critical extension of its hospice partners, providing full-service equipment delivery and maintenance through its highly trained technicians, enabling hospice agencies to focus on their core caregiving competencies. MDME’s five strategically located facilities enable the company to serve over 400 hospice agencies annually throughout southern California.

Incline Equity Partners, headquartered in Pittsburgh, Pennsylvania, is a private equity firm investing in manufacturing, distribution and business services companies. The firm seeks growing companies with enterprise values of US$25–750 million. Incline’s typical investment types are ownership transitions for privately held businesses, buy-outs and corporate divestitures within the US and Canada.

MMP is an independent private investment firm comprised of highly experienced and accomplished private equity and operational executives seeking to sponsor the acquisition of companies in the microcap market, which they define as companies with an EBITDA between US$2–8 million. Its focus is on businesses located in the US and Canada.

Oaklins TM Capital in the US served as the exclusive financial advisor to Montgomery DME, a portfolio company of Monument MicroCap Partners, in its sale to Incline Equity Partners.

Parties prenantes
«In choosing a financial advisor, Monument sought a firm that would not only engineer an exceptional outcome for its shareholders, but would also appreciate MDME’s culture of compassionate care and identify the right partner to support the company’s future growth. Through every step of the process, it rang clear that Monument made the right choice, given TM Capital’s extensive healthcare expertise, superior execution, senior level attention and relentless dedication. We sincerely appreciate our relationship with the team and the value that they have delivered consistently for decades.»

Glenn Scolnik

Chairman and Founding Partner, Monument MicroCap Partners, LLC

Contacter l'équipe de la transaction

Paul R. Smolevitz

Directeur général
New York, États-Unis
Oaklins TM Capital

John Dean

Directeur général
Atlanta, États-Unis
Oaklins TM Capital

Michael S. Goldman

Directeur général
New York, États-Unis
Oaklins TM Capital

James McLaren

Directeur général
New York, États-Unis
Oaklins TM Capital

Michael Sanseverino

Analyste
New York, États-Unis
Oaklins TM Capital

Transactions connexes

Hemink Groep has been acquired by Gimv
Placements Privés | Construction et Ingénierie | Immobilier

Hemink Groep has been acquired by Gimv

Gimv has acquired a majority stake in Hemink, a Dutch specialist in real estate renovation and maintenance. This transaction marks a new chapter for Hemink, as it seeks to expand its position as a national leader in sustainable property services through its new partnership with Gimv.

En apprendre plus
OGD has been sold to Building Beyond Technology Group
Placements Privés | TMT

OGD has been sold to Building Beyond Technology Group

Building Beyond Technology Group (BBTG) strengthens its position in the IT sector by welcoming OGD IT-Dienstverlening (OGD) to its platform. With over 1,400 employees, OGD is an established name in the Dutch market as a mission-critical IT service provider for large-scale clients. This addition not only increases BBTG’s scale but also enhances its domain expertise and execution capabilities through close cooperation with the other platform companies.

En apprendre plus
The Providence Projects has been acquired by UKAT Group
Placements Privés | Soins de la Santé

The Providence Projects has been acquired by UKAT Group

Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.

En apprendre plus